DOI: 10.1055/s-00000059

Pneumologie

References

Dooley KE, Sayre P, Borland J. et al.
Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects.

J Acquir Immune Defic Syndr 2013;
62: 21-27

Download Bibliographical Data

Access:
Access: